Published in Proc Natl Acad Sci U S A on April 28, 2014
Enhancer RNA facilitates NELF release from immediate early genes. Mol Cell (2014) 2.13
The Mediator complex: a central integrator of transcription. Nat Rev Mol Cell Biol (2015) 1.97
Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science (2015) 1.91
Ligand-dependent enhancer activation regulated by topoisomerase-I activity. Cell (2015) 1.74
Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription. Cell Rep (2014) 1.19
Enhancers as non-coding RNA transcription units: recent insights and future perspectives. Nat Rev Genet (2016) 1.15
Architectural and Functional Commonalities between Enhancers and Promoters. Cell (2015) 1.14
Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs. Proc Natl Acad Sci U S A (2015) 1.01
PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy. Cancer Res (2015) 0.93
RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin α-subunit gene. Proc Natl Acad Sci U S A (2015) 0.91
Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer. Genomics Proteomics Bioinformatics (2016) 0.91
The many faces of long noncoding RNAs. FEBS J (2014) 0.87
Long Noncoding RNA ADINR Regulates Adipogenesis by Transcriptionally Activating C/EBPα. Stem Cell Reports (2015) 0.87
A novel virus-inducible enhancer of the interferon-β gene with tightly linked promoter and enhancer activities. Nucleic Acids Res (2014) 0.84
Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer. Cell Rep (2016) 0.84
Epigenomics of macrophages. Immunol Rev (2014) 0.84
Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery. Cell Rep (2015) 0.83
Long non-coding RNA regulation of reproduction and development. Mol Reprod Dev (2015) 0.82
Structural aspects of the inactive X chromosome. Philos Trans R Soc Lond B Biol Sci (2017) 0.81
High-throughput functional comparison of promoter and enhancer activities. Genome Res (2016) 0.80
Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency-Associated Genes. Cell Rep (2016) 0.80
Enhancer alterations in cancer: a source for a cell identity crisis. Genome Med (2014) 0.80
Exploiting genomics and natural genetic variation to decode macrophage enhancers. Trends Immunol (2015) 0.79
Enhancer RNAs. Cell Cycle (2014) 0.79
Transcriptional enhancers: Transcription, function and flexibility. Transcription (2016) 0.77
Long noncoding RNAs: pivotal regulators in acute myeloid leukemia. Exp Hematol Oncol (2016) 0.77
Genome-wide analysis of enhancer RNA in gene regulation across 12 mouse tissues. Sci Rep (2015) 0.77
Genomic Views of Transcriptional Enhancers: Essential Determinants of Cellular Identity and Activity-Dependent Responses in the CNS. J Neurosci (2015) 0.77
Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer. Oncotarget (2016) 0.77
Diverse regulatory interactions of long noncoding RNAs. Curr Opin Genet Dev (2016) 0.76
Noncoding RNAs: Regulators of the Mammalian Transcription Machinery. J Mol Biol (2016) 0.76
Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster. Sci Rep (2016) 0.76
The C/ebp-Atf response element (CARE) location reveals two distinct Atf4-dependent, elongation-mediated mechanisms for transcriptional induction of aminoacyl-tRNA synthetase genes in response to amino acid limitation. Nucleic Acids Res (2016) 0.76
Effect of Interaction between Chromatin Loops on Cell-to-Cell Variability in Gene Expression. PLoS Comput Biol (2016) 0.76
RNA Binding to CBP Stimulates Histone Acetylation and Transcription. Cell (2017) 0.76
Analgesic use in pregnancy and male reproductive development. Curr Opin Endocrinol Diabetes Obes (2017) 0.75
Enhancers and chromatin structures: regulatory hubs in gene expression and diseases. Biosci Rep (2017) 0.75
Transcriptional landscape of the human cell cycle. Proc Natl Acad Sci U S A (2017) 0.75
TET2 binds the androgen receptor and loss is associated with prostate cancer. Oncogene (2016) 0.75
The Determinants of Directionality in Transcriptional Initiation. Trends Genet (2016) 0.75
Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets. Sci Rep (2016) 0.75
Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription. Nucleic Acids Res (2016) 0.75
A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer. Elife (2017) 0.75
SERPINB2 is regulated by dynamic interactions with pause-release proteins and enhancer RNAs. Mol Immunol (2017) 0.75
Transcriptional role of androgen receptor in the expression of long non-coding RNA Sox2OT in neurogenesis. PLoS One (2017) 0.75
Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell (2007) 30.22
Widespread transcription at neuronal activity-regulated enhancers. Nature (2010) 16.52
Long noncoding RNAs with enhancer-like function in human cells. Cell (2010) 13.00
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res (2006) 9.87
Androgen receptor in prostate cancer. Endocr Rev (2004) 7.92
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell (2009) 7.09
Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell (2011) 6.83
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell (2010) 6.76
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol (2011) 6.54
Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature (2011) 6.10
A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol (2010) 6.01
Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature (2013) 3.98
Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature (2013) 3.93
lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature (2013) 3.77
eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell (2012) 3.63
Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell (2013) 3.59
Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature (2013) 3.33
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J (2011) 2.97
Enhancer transcripts mark active estrogen receptor binding sites. Genome Res (2013) 2.82
Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell (2013) 2.56
Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol Metab (2010) 2.53
Mechanisms mediating androgen receptor reactivation after castration. Urol Oncol (2008) 2.35
eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol Cell (2013) 2.12
Evolution of the androgen receptor pathway during progression of prostate cancer. Cancer Res (2006) 1.83
Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells. Proc Natl Acad Sci U S A (2006) 1.77
Transcription of the HS2 enhancer toward a cis-linked gene is independent of the orientation, position, and distance of the enhancer relative to the gene. Mol Cell Biol (1997) 1.62
Long noncoding RNAs usher in a new era in the biology of enhancers. Cell (2013) 1.58
Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. Endocr Rev (2010) 1.54
Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth. EMBO J (2011) 1.33
Molecular states underlying androgen receptor activation: a framework for therapeutics targeting androgen signaling in prostate cancer. J Clin Oncol (2011) 1.30
Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays. Toxicol In Vitro (2006) 0.87
Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif. J Biol Chem (2011) 0.86